23 July 2019 - Paul Hazelwood was told there was nothing else doctors could do to treat his rare terminal cancer.

Three and a half years later he is still living with stage 4 small bowel cancer, a fact he puts down to a medical trial and a cancer drug called Keytruda.

"I owe it everything," Mr Hazelwood, 44, said.

In a big win for people with rare cancers, the Therapeutic Goods Administration (TGA) approved the use of Keytruda for multiple rare cancer types.

Read Sydney Morning Herald article